Rho

Rho inhibitors target the Rho family of GTPases, which are critical regulators of the cytoskeleton, cell division, and signal transduction pathways. Rho GTPases are involved in controlling the dynamics of actin filaments, cell shape, and motility, as well as progression through the cell cycle. Dysregulation of Rho signaling can lead to uncontrolled cell proliferation and cancer. Inhibiting Rho GTPases can induce cell cycle arrest and apoptosis, making these inhibitors valuable tools in cancer research and the study of cell motility. At CymitQuimica, we offer a range of high-quality Rho inhibitors to support your research in cell cycle regulation, cytoskeletal dynamics, and oncology.